WHO Issues First Guidelines for Type 1 Diabetes in Adults: Focus on Insulin Access and Effective Treatment
WHO Issues First-Ever Guidelines for Type 1 Diabetes in Adults: Emphasis on Insulin Availability and Effective Treatment
Why in News?
On November 14, 2026, on the occasion of World Diabetes Day, the World Health Organization (WHO) released its first-ever dedicated guidelines for the diagnosis and management of Type 1 diabetes in adults.
The objective is to ensure the availability of affordable insulin, regular blood glucose monitoring, and quality treatment. These guidelines can also be implemented in resource-limited settings and during emergency and humanitarian crises.
What is Type 1 Diabetes?
Type 1 diabetes is an autoimmune disease in which the body's immune system destroys the insulin-producing beta cells of the pancreas, leading to a severe deficiency of insulin in the body.
- This disease can develop in both children and adults.
- Regular insulin treatment is essential for patients to survive.
- Major symptoms include excessive thirst, frequent urination, weight loss, and fatigue.
- Unlike Type 2 diabetes, Type 1 diabetes is primarily related to an autoimmune process.
Key Recommendations of WHO's New Guidelines
- Insulin Treatment: Recommends multiple daily insulin injections, adjusting doses according to blood sugar levels.
- Human Insulin: Human insulin has been considered an effective and suitable option due to its relatively lower cost. Insulin analogues can also be used as needed.
- Glucose Monitoring: Use of regular blood glucose testing, finger-prick tests, and Continuous Glucose Monitoring (CGM).
- HbA1c Testing: Assessment of the average blood sugar level over the past two to three months.
- Resource-Limited Settings: Urine glucose testing may be considered when blood glucose testing is unavailable; however, it is not a complete substitute for blood glucose testing.
Global Situation and Important Statistics
- According to WHO, approximately 9.5 million people worldwide were affected by Type 1 diabetes in 2025, with over half a million new cases reported that same year.
- In 2022, approximately 830 million people worldwide were affected by all forms of diabetes.
- Uncontrolled diabetes can lead to severe complications such as blindness, kidney failure, heart attacks, strokes, and lower-limb amputations.
Global Health Goals and Significance for India
- WHO launched the Global Diabetes Compact in 2021.
- A major global target is to ensure universal access to affordable insulin and self-monitoring of blood glucose for all individuals affected by Type 1 diabetes by 2030.
- In India, the significance of these guidelines is particularly linked to rural health services, insulin availability, timely diagnosis, and continuity of care.
Conclusion
WHO's new guidelines are a significant step toward making Type 1 diabetes management more accessible, affordable, and patient-centered. Their success will depend on affordable insulin, regular monitoring, and robust primary healthcare services.
Multiple-Choice Question
Question: With reference to Type 1 diabetes and WHO's 2026 guidelines, consider the following statements:
- Type 1 diabetes is an autoimmune disease in which the insulin-producing beta cells of the pancreas are destroyed.
- WHO has recommended the use of insulin analogues exclusively for the treatment of Type 1 diabetes.
- The HbA1c test indicates the average blood sugar level over the past two to three months.
- WHO aims to ensure affordable insulin and self-monitoring of blood glucose for all individuals affected by Type 1 diabetes by 2030.
Which of the statements given above are correct?
(A) 1, 2 and 3 only
(B) 1, 3 and 4 only
(C) 2, 3 and 4 only
(D) 1, 2, 3 and 4
Answer: (B)
Explanation: Statements 1, 3 and 4 are correct. Type 1 diabetes is an autoimmune disease, and HbA1c is an indicator of long-term blood sugar control. WHO has set a target for universal access to affordable insulin and self-monitoring of blood glucose by 2030. Statement 2 is incorrect because WHO has accepted the use of both human insulin and insulin analogues, prioritizing human insulin due to its lower cost.
More Current Affairs - Daily
- India’s State Capacity Stagnation: The Missing Link in Reform 21 Nov 2026
- Holding Two Offices: What Does the Constitution Say About an Office of Profit? 21 Nov 2026
- The Price of War: West Asia Crisis Is Raising India’s Energy Import Bill 21 Nov 2026
- Surveillance Pricing : How Is Personal Data Used to Set Prices? 21 Nov 2026